Pulmovant
Sabina Waid is an accomplished accounting professional currently serving as Assistant Controller at Pulmovant since February 2024. Prior to this role, Sabina held various positions at Proteovant Therapeutics, including Senior Accounting Manager and Accounting Manager from April 2021 to August 2023. Sabina's career began at KPMG US, where responsibilities included Audit Manager, Senior Audit Associate, and Audit Associate from September 2015 to March 2021. Earlier experiences include leadership roles at ALPFA San Diego, where Sabina was the Director of Membership and Director of Student Affairs, and multiple internships at KPMG US and a corporate management internship. Sabina’s experience also includes bookkeeping at e-Accounting Department and lifeguarding at Westview High School. Sabina earned a Bachelor of Science in Accounting from San Diego State University in 2015.
This person is not in the org chart
This person is not in any teams
Pulmovant
Pulmovant is a clinical-stage biotechnology company developing innovative therapies for patients suffering from pulmonary diseases. Pulmovant’s first program, mosliciguat is designed to provide an effective, once-daily, inhaled treatment option for patients with pulmonary hypertension (PH). Mosliciguat is a novel, potential first-in-class, sGC activator with a differentiated mechanism that may have broad applicability across the PH spectrum.